Drug intelligence / Profile preview

Daemonorops draco Blume

Development stage
Preclinical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Topical, Oral
01

Overview

Daemonorops draco Blume (DD), commonly known as dragon's blood, is a resinous secretion obtained from the fruit of the *Daemonorops draco* palm tree. Traditionally utilized in Korean and Chinese medicine for its analgesic, antibacterial, and wound-healing properties, recent research has focused on its potential antineoplastic effects. In preclinical studies involving acute myeloid leukemia (AML) cell lines, DD has been shown to induce apoptosis through the accumulation of reactive oxygen species (ROS) and the activation of the miR-216b/c-Jun/CHOP signaling pathway. This process involves the reduction of mitochondrial membrane potential and the activation of executioner caspases such as caspase-3. The cytotoxic effects of DD can be reversed by antioxidants like N-acetyl-L-cysteine, confirming the central role of oxidative stress in its mechanism of action.

Other names
Dragon's bloodSanguis DraconisLong Xue JieDD
02

Targets

CASP3 (Caspase-3)ChoP (Phosphorylcholine)JUN (Transcription factor Jun)

Beyond the preview

Go deeper on Daemonorops draco Blume.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daemonorops draco Blume.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call